The company plans to sell its holdings of Green Bamboo Biology and Kang Le Wei Shi stocks according to the securities market conditions. The company currently holds 13.7515 million shares of Green Bamboo Biology, accounting for 6.79% of its total share capital; and holds 1.364 million shares of Kang Le Wei Shi, accounting for 0.486% of its total share capital.
赛升药业：拟择机出售所持绿竹生物及康乐卫士股票
Beijing Science Sun Pharmaceutical: plans to selectively sell its shares in Lvzhuo Biotech and Kang Le Weishi stocks.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated